# Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring

> **NCT06562023** · NA · COMPLETED · sponsor: **Hams Hamed Abdelrahman** · enrollment: 33 (actual)

## Conditions studied

- Facial Scars

## Interventions

- **OTHER:** Botulinum Toxin Type A
- **OTHER:** Mesotherapy

## Key facts

- **NCT ID:** NCT06562023
- **Lead sponsor:** Hams Hamed Abdelrahman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-19
- **Primary completion:** 2024-07-20
- **Final completion:** 2024-07-20
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06562023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06562023, "Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06562023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*